Drug therapy during breastfeeding

Abstract

The importance of breastfeeding for the health of mothers and children does not need to be proven at this time. However, there are many reasons that can prevent full breastfeeding. In particular, drug therapy prescribed during lactation often leads to the temporary discontinuation of breastfeeding, sometimes unreasonable. Often this leads to a loss of breastfeeding in the future. This article highlights the difficulties of prescribing drug therapy during lactation, the contradictions between the existing worldwide recommendations and the instructions for the drug, reflects the current aspects of the pharmacokinetics of drugs in breast milk and gives practical recommendations on the way to solve those problems.

Keywords:lactation, breastfeeding, drug therapy, pharmacodynamics of drugs, pharmacokinetics of drugs, drugs for nursing, antibacterial therapy for lactation, physiology of lactation

For citation: Levadnaya A.V., Zhdanova S.I. Drug therapy during breastfeeding. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2019; 7 (4): 79-84. doi: 10.24411/2308-2402-2019-14006 (in Russian)

References

1. Davanzo R. Controversies in breastfeeding. Front Pediatr. 2018; 1 (6): 278.

2. Illamola S.M., Bucci-Rechtweg C., Costantine M.M., Tsilou E., et al. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives. Br J Clin Pharmacol. 2018; 84 (2): 215-22.

3. Aydin B., Nayir T., Sahin S., Yildiz A. Olanzapine and quetiapine use during breastfeeding: Excretion into breast milk and safe breastfeeding strategy. J Clin Psychopharmacol. 2015; 35 (2): 206-8.

4. Arguello B., Salgado T.M., Fernandez-Llimos F. Assessing the information in the summaries of product characteristics for the use of medicines in pregnancy and lactation. Br J Clin Pharmacol. 2015; 79: 537-44.

5. URL: https://grls.rosminzdrav.ru/Default.aspx

6. Order of the Ministry of Health of the Russian Federation of May 10, 2017 No. 203n "On the Approval of Criteria for Assessing the Quality of Medical Care". (in Russian)

7. Rowe H., Baker T., Hale T.W. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am. 2013; 60: 275.

8. National Library of Medicine LactMed Database. URL: http://toxnet. nlm.nih.gov (date of access September 2019)

9. URL: https://toxnet.nlm.nih.gov/help/newtoxnet/lactmedapp.htm

10. Hale T. Medications and Mothers’ Milk. 14th ed. Amarillo, TX: Hale Publishing, 2010.

11. Kaplan Y.C., Keskin-Arslan E., Acar S., et al. Teicoplanin use during breastfeeding. Breastfeed Med. 2017; 12: 124.

12. Fraissinet F., Lesourd M., Naudoux N., et al. Pharmacokinetics of teicoplanin in a breastfeeding mother. Breastfeed Med. 2017; 12: 244-6.

13. Festini F., Ciuti R., Repetto T., et al. Safety of breast-feeding during an IV tobramycin course for infants of CF women. Pediatr Pulmonol Suppl. 2004; 27: 288-9.

14. Boda A. Gentamicin concentration in the milk of a mother after treatment by implants of a Septopal chain. Orv Hetil. 1990; 131: 2263-5.

15. Celiloglu M., Celiker S., Guven H., et al. Gentamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol. 1994; 84: 263-5.

16. Cherif F., El Aidli S., Kastalli S., et al. Drug induced urticaria via breastfeeding. Fundam Clin Pharmacol. 2009; 23 (suppl 1): 37.

17. Berens P., Eglash A., Malloy M., et al. ABM Clinical Protocol No. 26: Persistent pain with breastfeeding. Breastfeed Med. 2016; 11: 46-53.

18. Manninen A.K., Juhakoski A. Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. Int J Clin Pharm Res. 1991; 11: 231-6.

19. Duke M.E., Britten F.L., Pretorius C.J., et al. Maternal metyrapone use during breastfeeding: Safe for the breastfed infant. J Endocr Soc. 2019; 3: 973-8.

20. Ryu R.J., Easterling T.R., Caritis S.N., et al. Prednisone pharmacokinetics during pregnancy and lactation. J Clin Pharmacol. 2018; 58: 1223-32.

21. Smuin D.M., Seidenberg P.H., Sirlin E.A., et al. Rare adverse events associated with corticosteroid injections: a case series and literature review. Curr Sports Med Rep. 2016; 15: 171-6.

22. Davanzo R., Bua J., Paloni G., Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014; 70 (11): 1313-24.

23. Anderson P.O., Manoguerra A.S., Valdes V. A review of adverse reactions in infants from medications in breastmilk. Clin Pediatr (Phila). 2016; 55: 236-44.

24. Constantinescu S., Pai A., Coscia L.A., et al. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014; 28: 1163-73.

25. Flint J., Panchal S., Hurrell A., et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding - part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016; 55: 1693-7.

26. Gotestam Skorpen C., Hoeltzenbein M., Tincani A., et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016; 75: 795-810.

27. Brucker M.C., King T.L. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule. J Midwifery Womens Health. 2017; 62 (3): 308-16.

28. Crettenand M., Rossetti A.O., Buclin T., Winterfeld U. Use of antiepileptic drugs during breastfeeding: what do we tell the mother? Nervenarzt. 2018; 89 (8): 913-21.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Degtyarev Dmitriy Nikolaevich
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Research of the V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Head of the Chair of Neonatology at the Clinical Institute of Children's Health named after N.F. Filatov, I.M. Sechenov First Moscow State Medical University, Chairman of the Ethics Committee of the Russian Society of Neonatologists, Moscow, Russian Federation

ORCID iD 0000-0001-8975-2425

Journals of «GEOTAR-Media»